Combined Cardiac Panel
New York
Approved
Genes
Conditions
- Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
- Dilated Cardiomyopathy (DCM)
- Hypertrophic Cardiomyopathy (HCM)
- Left Ventricular Noncompaction (LVNC)
- Long QT Syndrome (LQTS)
- Noonan Syndrome
- Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Short QT Syndrome (SQTS)
- Sudden Cardiac Arrest
- Brugada Syndrome
Clinical Utility
- Molecular confirmation of a clinical diagnosis in symptomatic patients
- Risk assessment of asymptomatic family members of a proband with cardiomyopathy and/or arrhythmia
- Differentiation of hereditary cardiomyopathy and/or arrhythmia from acquired (non-genetic) cardiomyopathy and/or arrhythmia
- Recurrence risk calculation
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Important Information
ATTENTION: Effective August 27, 2024, this test is available for institutional billing and self-pay only. Insurance billing not accepted.
Test Code
935
CPT Codes*
81413x1, 81414x1
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
For Providers
Targeted Variant Testing